Company / Cash & Equivalents
AMREP CORP. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$39.5M
FY2025
5-year range
$15.7M / $39.5M
FY2021-FY2025
Trend
+32.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has increased for 3 consecutive years, from $16M in FY2022 to $39M in FY2025.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of +17.7%.
Improved from $20M to $39M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +35.9%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- AMREP CORP.'s cash & equivalents has grown for 3 consecutive years.
- 5-year CAGR of +17.7%, indicating consistent growth.
- In FY2025, cash & equivalents increased 32.9% year-over-year.
- Lowest cash & equivalents in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.5M | +32.9% |
| FY2024 | $29.7M | +48.5% |
| FY2023 | $20.0M | +27.2% |
| FY2022 | $15.7M | -36.6% |
| FY2021 | $24.8M | +41.7% |
| FY2020 | $17.5M | +31.9% |
| FY2019 | $13.3M | +22.3% |
| FY2018 | $10.9M | -8.1% |
| FY2017 | $11.8M | -2.0% |
| FY2016 | $12.1M | +59.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026